Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 16Amifostine 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Paclitaxel 4Donepezil 4sargramostim 3Radiosurgery 3Low-Level Light Therapy 3Filgrastim 3Etoposide 3Carboplatin 3Surveys and Questionnaires 2Radiation 2Magnetic Resonance Spectroscopy 2Esophagectomy 2Diet Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2Bevacizumab 2olaparib 1ethanethiol 1delta 24-sterol reductase 1cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vitamin E 1Vincristine 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Radiation Injuries × Mometasone Furoate × Clear all
NCT00438659 2016-08-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Alliance for Clinical Trials in Oncology

Phase 3 Completed
176 enrolled 10 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiation Injuries, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡